Global Genetic Testing Market Report 2022: Market to Reach $17.3 Billion by 2026 - Genetic Testing Paves the Way for Personalized Medicine
24 mars 2022 09h08 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Genetic Testing Market...
Insights on the Cell and Gene Therapy World Market to 2031 - by Product Segments, Method and Geographical Region
24 mars 2022 07h03 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy World Market and Market Potential" report has been added to ResearchAndMarkets.com's offering. The report examines...
Viral Vectors and Plasmid DNA Global Market (2021 to 2026) - Featuring FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Renova Therapeutics and Genzyme Corporation
24 mars 2022 06h03 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Global Market Report 2022: By Product, By Application, By Disease, By End-User" report has been added to...
Global Whole Genome and Exome Sequencing Markets Report 2022-2026: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing - A New Industry Emerges
23 mars 2022 05h13 HE
|
Research and Markets
Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer...
Global Single Cell Genomics Markets Report 2022: Immuno-oncology, Research Range, Technology Maturity & Convergence, & Declining Costs Driving Growth
23 mars 2022 05h08 HE
|
Research and Markets
Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "Single Cell Genomics Markets: Forecasts by Technology, Product, Workflow, User & Country with Executive and Consultant Guides. Including...
InnoSIGN schließt den Spin-off von Philips mit einer Serie A-Finanzierung in Höhe von 8 Mio. USD ab, um die Präzisionsmedizin durch seine OncoSIGNal Pathway Activity Profiling Plattform zu revolutionieren
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN nutzt seine firmeneigene Datenbank mit über 100.000 Aktivitätsprofilen von Signalwegen für die Arzneimittelentwicklung und Diagnostik, um das Ansprechen von Patienten auf zielgerichtete...
InnoSIGN se sépare de Philips au moyen d'un financement de série A de 8 millions USD pour révolutionner la médecine de précision via sa plateforme de profilage de l'activité des voies cellulaires OncoSIGNal
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN emploie sa base de données exclusive contenant plus de 100 000 profils d'activité des voies cellulaires, pour le développement de médicaments et pour les diagnostics afin de prédire la...
InnoSIGN Completes Spin-Out from Philips with an $8M Series A Financing to Revolutionize Precision Medicine through its OncoSIGNal Pathway Activity Profiling Platform
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN utilizes its proprietary database with over 100,000 pathway activity profiles for drug development and diagnostics to predict patient response to targeted therapies Proceeds support...
Worldwide Cell and Gene Therapy Bioassay Services Industry to 2030 - Featuring CCRM, Nexelis and Pacific BioLabs Among Others
22 mars 2022 06h48 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Bioassay Services Market by Type of Therapy, Therapeutic Area, Scale of Operation and Geography: Industry Trends and Global...
Global Gene Editing Beyond CRISPR Market (2022 to 2035) - Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies
22 mars 2022 06h13 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies:...